Eli Marom
Overview
Explore the profile of Eli Marom including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
89
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schwartzberg E, Marom E, Vishkautzan A, Gorelik E, Shani S
Isr J Health Policy Res
. 2024 Mar;
13(1):14.
PMID: 38500149
Background: In 2017, we published an article addressing drug shortages (DS) in Israel, exploring regulatory perspectives, challenges, and potential solutions. Since then, DS remain a significant concern for patients, healthcare...
2.
Schwartzberg E, Marom E, Trainin M, Lavon O, Shani S
Harefuah
. 2024 Mar;
163(2):79-84.
PMID: 38431854
Drug therapy is a central pillar in the provision of medical care. A significant number of doctor-patient encounters conclude with a prescription for a drug. These are subsequently followed by...
3.
Hiayev S, Shacham-Shmueli E, Berkovitch M, Weiss I, Ashkenazi S, Vexberg M, et al.
BMJ Open
. 2023 May;
13(5):e067313.
PMID: 37142315
Objectives: US FDA and EMA allow facilitated regulatory pathways to expedite access to new treatments. Limited supportive data may result in major postapproval variations. In Israel, partly relying on Food...
4.
Berman T, Barnett-Itzhaki Z, Berman T, Marom E
Isr J Health Policy Res
. 2023 Apr;
12(1):18.
PMID: 37101188
Background: Development of antimicrobial resistance poses a major threat to human and animal health worldwide. Antimicrobials are frequently used in animal husbandry, making food-producing animals a widespread and important source...
5.
Schwartzberg E, Marom E
Isr J Health Policy Res
. 2021 Dec;
10(1):72.
PMID: 34903284
Clinical pharmacy is an umbrella of pharmaceutical services that is practiced by clinical pharmacists. Clinical pharmacists improve the quality of drug therapy, minimize the risk for drug related problems, reduce...
6.
Schwartzberg E, Nathan J, Avron S, Marom E
Isr J Health Policy Res
. 2018 Dec;
7(1):59.
PMID: 30501624
The community pharmacy setting is a venue that is readily accessible to the public. In addition, it is staffed by a pharmacist, who is a healthcare provider, trained and capable...
7.
Ponizovsky A, Marom E, Weizman A, Schwartzberg E
Pharmacoepidemiol Drug Saf
. 2018 Mar;
27(5):535-540.
PMID: 29488288
Purpose: The purpose of the study is to assess opioid (morphine, methadone, oxycodone, pethidine, and fentanyl) consumption in Israel during 2009 to 2016 and identify recent trends. Methods: Data for...
8.
Schwartzberg E, Nathan J, Rosen B, Marom E
Am J Health Syst Pharm
. 2017 Dec;
75(1):e57-e61.
PMID: 29273614
No abstract available.
9.
Berman E, Eyal S, Marom E
Pharmacoepidemiol Drug Saf
. 2017 Oct;
26(12):1555-1560.
PMID: 29027336
Background: Studies on benzodiazepine (BZDs) as well as Zopiclone and Zolpidem (Z-drugs) utilization are important for estimating the prevalence of medical conditions, providing the basis for pharmacovigilance, and identifying temporal...
10.
Schwartzberg E, Barnett-Itzhaki Z, Grotto I, Marom E
Isr J Health Policy Res
. 2017 Oct;
6(1):50.
PMID: 28962636
The correct and rational use of medications can have a positive direct impact on disease outcomes, as well on the utilization of the health system resources. Unfortunately, 50% of the...